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Abstract
Background: Leptospirosis is a multisystem disease caused by pathogenic strains of the genus Leptospira. We have reported
that Leptospira are able to bind plasminogen (PLG), to generate active plasmin in the presence of activator, and to degrade
purified extracellular matrix fibronectin.
Methodology/Principal Findings: We have now cloned, expressed and purified 14 leptospiral recombinant proteins. The
proteins were confirmed to be surface exposed by immunofluorescence microscopy and were evaluated for their ability to
bind plasminogen (PLG). We identified eight as PLG-binding proteins, including the major outer membrane protein LipL32,
the previously published rLIC12730, rLIC10494, Lp29, Lp49, LipL40 and MPL36, and one novel leptospiral protein, rLIC12238.
Bound PLG could be converted to plasmin by the addition of urokinase-type PLG activator (uPA), showing specific
proteolytic activity, as assessed by its reaction with the chromogenic plasmin substrate, D-Val-Leu-Lys 4-nitroanilide
dihydrochloride. The addition of the lysine analog 6-aminocaproic acid (ACA) inhibited the protein-PLG interaction, thus
strongly suggesting the involvement of lysine residues in plasminogen binding. The binding of leptospiral surface proteins
to PLG was specific, dose-dependent and saturable. PLG and collagen type IV competed with LipL32 protein for the same
binding site, whereas separate binding sites were observed for plasma fibronectin.
Conclusions/Significance: PLG-binding/activation through the proteins/receptors on the surface of Leptospira could help
the bacteria to specifically overcome tissue barriers, facilitating its spread throughout the host.
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Introduction
Leptospirosis is an emerging infectious disease with worldwide
distribution and a zoonosis that is of human and veterinaryconcern.
Pathogenic Leptospira are the etiological agents of leptospirosis, a
disease with greater incidence in tropical and subtropical regions
[1,2,3,4,5]. Leptospires cause chronic infectionindomestic andwild
mammalian species that harbor the bacteria in their renal tubules,
shedding them through the urine into the environment, thus
constituting a source of re-infection in other animals. Humans are
accidental and terminal hosts in the transmission process of
leptospirosis [3,6]. Leptospirosis represents a great economic
burden as it affects the public health system and livestock [3].
The molecular pathogenesis of leptospirosis is poorly under-
stood. To date, few virulence factors contributing to the
pathogenesis of the disease have been identified [7,8,9]. It is well
documented that the interaction of pathogens with the extracel-
lular matrix (ECM) may play a primary role in the colonization of
host tissues, as long-lasting infections may occur if microorganisms
reach the sub-epithelial tissues [10]. Recently, the ability of the
leptospires to adhere to ECM macromolecules has been shown,
and some adhesins, ECM-binding proteins, have been identified
[9,11,12,13,14,15,16,17,18,19]. However, under normal condi-
tions, ECM is not exposed to bacteria. The proteolytic activity
achieved by subversion of host proteases by pathogens, such as
plasmin, has been demonstrated to be important in various
bacterial infections [20]. Plasmin is a broad-spectrum serine
protease component of the fibrinolytic system, which has the
zymogen plasminogen (PLG) as its main component.
In our previous work, we found that Leptospira species are able to
bind PLG and generate plasmin, in the presence of activator, on
the outer surface in vitro [21], an activity already shown for the
pathogenic spirochetes Borrelia and Treponema [22,23,24,25,26]. We
have also revealed that leptospires express multiple PLG-binding
proteins, as reported for other microorganisms. Recently, Verma
et al. [27] have shown that the protein LenA of L. interrogans [14],
formerly LfhA/Lsa24 [12,27], is a surface receptor for human
plasminogen.
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recombinant proteins of Leptospira to mediate binding to PLG in
vitro. Eight of the 14 assayed were identified as novel PLG-receptor
proteins, including the major outer membrane protein LipL32
[28], the previously published rLIC12730, rLIC10494, Lp29,
Lp49, LipL40 and MPL36 [29,30,31], and one novel leptospiral
protein rLIC12238. Bound PLG could be converted to plasmin by
the addition of urokinase-type PLG activator (uPA), showing
specific proteolytic activity. We also show that PLG interaction
with LipL32, also an ECM adhesin, was affected by collagen type
IV but not plasma fibronectin. Our data provide an array of novel
leptospiral receptors for human plasminogen, which constitutes an
important step for the understanding of the molecular pathogen-
esis and infection process of these bacteria.
Results
Selection of putative surface proteins from genome
sequences
The rationale for protein selection was mostly based on cellular
localization, since surface proteins are potential receptors for PLG.
Fourteen proteins available in our laboratory were selected: twelve
were previously published, LipL32 [28,32], LipL40, MPL36 [29],
rLIC10509 [33], Lp29, Lp49 [30], Lsa27 [11], MPL21, MPL17
[31], rLIC10494, rLIC12730 [12], and Lsa63 [19], and two are
novel proteins, rLIC12922 and rLIC12238. Table 1 summarizes
the features of the selected proteins and gene conservation within
the sequenced genomes [34,35,36,37].
Expression and purification of recombinant proteins
The amplified coding sequences, excluding the signal peptide
tags, were cloned and expressed as full-length proteins in E. coli.
Gene locus, protein reference number, given name, sequences of
primers used for PCR amplifications and molecular mass of
recombinants are depicted in Table 1. The recombinant proteins
were purified by nickel affinity chromatography, and an aliquot of
each protein was analyzed by SDS-PAGE (Fig. 1). All purified
proteins were represented by major bands, although in some cases
such as Lsa27 and MPL21, other less intense protein bands were
also observed. Structural integrity of the purified proteins not
previously published, LipL40, MPL36, rLIC12922 and
rLIC12238, was assessed by CD spectroscopy. The minima at
208 and 222 nm, and the maximum at 192 nm in the CD
spectrum showed the high a-helical secondary structure content of
the recombinant proteins LipL40, MPL36 and rLIC12922, while
rLIC12238 showed a predominant signal of b-strands, with
minimum ellipticity around 215 nm (data not shown).
Cellular localization of the recombinant proteins
To determine whether the proteins not previously character-
ized, namely Lp29, Lp49, LipL40, MPL36, rLIC10494,
rLIC12730, rLIC12922 and rLIC12238, are surface-exposed
proteins, we set out to analyze the corresponding protein location
on the bacteria using living L. interrogans serovar Copenhageni cells
and the liquid-phase immunofluorescence method. Leptospires
were visualized by propidium iodide staining followed by protein
detection with polyclonal mouse antiserum raised against the
protein in the presence of anti-mouse IgG antibodies conjugated to
FITC. The localization of the protein-green light lying on the
leptospires was achieved by superimposing the two fields, and the
results obtained are shown in Fig. 2. For each protein, two fields
are depicted where we can see, in general, green fluorescence spots
along the bacteria. An intense green fluorescence could be
observed for LipL32, a well-known major outer membrane
protein of Leptospira, used as a positive control [38], but not with
GroEL, a protoplasmic-cylinder marker used as a negative control
[39]. The PBS control showed only red fluorescence of leptospires
stained with propidium iodide.
Recombinant leptospiral proteins bind human
plasminogen
We have reported that L. interrogans binds PLG and that several
proteins could act as receptors [21]. These data prompted us to
investigate whether the selected surface-exposed proteins are
capable of binding human PLG in vitro. We have employed
Western blotting assay as a first screening to identify PLG-binding
proteins. The results show that the proteins LipL32, Lp29, Lp49,
LipL40, MLP36, rLIC10494, rLIC12730 and rLIC12238 were
interacting with PLG, while no binding was seen with Lsa63,
Lsa27, rLIC10509, MPL21, MPL17, rLIC12730 and rLIC12922
(Fig. 3A). In addition, the data clearly indicate that binding only
occur with the expected molecular mass corresponding to the
recombinant proteins (Fig. 3A). The binding of the proteins to
PLG was also evaluated by ELISA. The fourteen recombinant
leptospiral proteins, and BSA, used as negative control, were
individually immobilized onto 96-wells plates, incubated with
human PLG and the results obtained from three independent
experiments are shown in Fig. 3B. Proteins LipL32, Lp29, Lp49,
LipL40, MLP36, rLIC10494 and rLIC12238 presented statisti-
cally significant binding to PLG (*P,0.001 and **P,0.0001),
while proteins, Lsa63, Lsa27, rLIC10509, MPL21, MPL17,
rLIC12730, rLIC12922 and BSA did not show significant binding
activity (Fig. 3B). The ELISA data are in agreement with the one
obtained with Western blotting except for rLIC12730 and
rLIC12238 that show discrepancy in binding with the two
methodologies. The rLIC12730 depicted a stronger binding by
Western blotting when compared to ELISA data, while
rLIC12238 showed an opposite behavior (Fig. 3A, 3B).
Comparison of encoding sequences of the detected
leptospiral plasminogen-binding proteins and those of
published plasminogen-binding proteins
To investigate whether the identified PLG-binding proteins
showed sequence similarity with other published spirochetal PLG-
binding proteins [40,41,42,43,44], we carried out sequence
alignment analysis using the Clustal X program and a tree-display
NJ plot [45,46]. The constructed dendrogram showed that
leptospiral PLG-binding proteins do not display sequence
similarity or share conserved domains with other reported
spirochetal PLG-binding proteins (data not shown).
Role of lysine residues in the plasminogen binding
activity
It is known that PLG kringle domains frequently mediate
interactions with lysine residues of the bacterial receptors [20].
These domains participate in the binding of PLG with intact live
L. interrogans serovar Copenhageni strain L1–130, since the
derivative and analogue of lysine, ACA, almost totally inhibited
binding [21]. Sequence analysis showed that the native PLG
binding proteins, LipL32, Lp29, Lp49, LipL40, MPL36,
LIC10494, LIC12238 and LIC12730, contain 9.6, 9.3, 10.7,
7.8, 10.6, 9.1, 8.8 and 5.5% lysine residues, respectively. Based on
these findings, the participation of lysine residues in the binding of
the recombinant proteins was evaluated by the addition of ACA to
the assay. As depicted in Fig. 4A, when 2 mM ACA was added to
the reaction, the binding of the proteins to PLG was almost
completely abolished.
PLG-Receptors of Leptospira
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DNA amplification, and molecular mass of expressed recombinant proteins.
Gene locus
1
Recombinant
protein
given name
NCBI
reference
sequence
number
2
Description/
Function
Conservation
(identity)
3
Sequence of primers
for PCR amplification
Recombinant
protein
molecular
mass [70]
LIC11352 LipL32
a YP_001316 Major outer membrane protein
(MOMP), LipL32 lipoprotein
Lai (100%);
LBH (98%)
F: 59 CACCGGTGCTTTCGGTGGTCTG 39 30.2
R: 59 ATTACTTAGTCGCGTCAGAAGC 39
LIC10314 Lsa63
b YP_000304 Conserved hypothetical protein
with Borrelia_P83 domain
Lai (98%);
LBH (87%)
F: 59 GGATCCTTATTTTCTCAGGAAAG 39
(BamH I)
63.0
LBP (39%) R: 59 GGTACCCTAAGGTTTAATTTTTTT 39 (Kpn I)
LIC10509 rLIC10509
c YP_000493 Putative lipoprotein Lai (98%) F: 59 CCGGGATCCAAAAAGAGCAAAGAAG 39
(BamH I)
22.0
R: 59 GGTACCCTACTCGAGACAGCCAGGA-
CCTTC 39 (Kpn I)
LIC12892 Lp29
d YP_002808 Putative lipoprotein F: 59 CTCGAGGCAGTACATTACAATC-
TTGCT 39 (Xho I)
29.6
R: 59 CCATGGCTCTTAGGAGCCTGGAAA 39 (Nco I)
LIC10793 Lp49
d YP_000772 Putative lipoprotein,
Surface antigen
Lai (99%);
LBH (86%)
F: 59 CTCGAGAGCGGAGACTTTTCTTTACTT 39
(Xho I)
49.1
R: 59 CCATGGTTAAAAACCATCTCTACG-
ATAAAC 39 (Nco I)
LIC12895 Lsa27
e YP_002811 Putative lipoprotein Lai (79%) F: 59 GGATCCCTGAAATATACGAA 39 (EcoRI) 27.0
R: 59 GAATTCTTACTGTTCTCCTTC 39 (BamHI)
LIC13131 MPL21
a,f YP_003039 Hypothetical protein
with Ycel domain
Lai (98%);
LBP (45%)
F: 59 CACCACGTCTCAAAGTTACGCTTCAG 39 21.9
R: 59 TTCTCACCATCCAGCTCGG 39
LIC10765 MPL17
a,f YP_000745 Conserved hypothetical
protein
Lai (100%);
LBH (80%)
F: 59 CACCGAAAGTCCCGTAAGGTTCAAA 39 15.4
LBP (41%) R: 59 TGCAGGAGTTCCCACATTTTA 39
LIC10091 LipL40
a YP_000088 Putative lipoprotein Lai (100%);
LBH (84%)
F: 59 CCATGGGACTCGAGACGCCTCCTCC-
TAAAGATCC 39
39.0
R: 59 CTCCATGGTCATTTCAAAACTT-
CTACGGGGC 39
LIC10054 MPL36
a YP_000054 Putative lipoprotein with Rare
lipoprotein A (RplA) like domain
Lai (100%);
LBH (88%)
F: 59 CACCACGTCTTGTGCGTCGGTAGAG 39 35.1
LBP (50%) R: 59 CCAAGTATTCTATTTATACGTCCGAG 39
LIC10494 rLIC10494
g YP_000478 Putative lipoprotein Lai (99%) F: 59 CACCACTGCTAGGGCTGCAGAAA 39 25.8
R: 59 ACTTTGAGAGCTTCGTCTCGT 39
LIC12730 rLIC12730
g YP_002650 Hypothetical protein with TPR
domain and 4 NHL repetition
Lai (100%);
LBH (90%)
F: 59 CACCAGTTCTGACGGACTTCCCAA 39 77.4
LBP (37%) R: 59 TCTTGCGAATGAGTTGATCC 39
LIC12922 rLIC12922
h YP_002837 Conserved hypothetical protein Lai (100%);
LBH (89%)
F: 59 CACCGAATCACTCAACAGAGTCATTGC 39 40.0
LBP (48%) R: 59 ATCAATCTAAATGAAACGTCTCTTC 39
LIC12238 rLIC12238
h YP_002173 Putative lipoprotein Lai (100%);
LBH (81%)
F: 59 CTCGAGTGTTTTAAACCTACCGGAG 39
(Xho I)
17.6
LBP (39%) R: 59 AAGCTTCTACTTCATCGCTTTTTCTATATC
39 (Hind III)
1http://aeg.lbi.ic.unicamp.br/world/lic/ [35].
2http://www.ncbi.nlm.nih.gov/protein/.
3Protein BLAST - http://www.ncbi.nlm.nih.gov/blast/Blast.cgi [71,72].
aPreviously published by Gamberini et al. [29].
bVieira et al. [19].
cPreviously published by Go ´mez et al. [33].
dPreviously published by Neves et al. [30].
ePreviously published by Longhi et al. [11].
fPreviously published by Oliveira et al. [31].
gPreviously published by Barbosa et al. [12].
hThis work; Lai: L. interrogans serovar Lai [34]; LBH: L. borgpetersenii serovar Hardjo-bovis [36]; LBP: L. biflexa serovar Patoc [37].
doi:10.1371/journal.pone.0011259.t001
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PLG bound to the surface of L. interrogans is converted to
enzymatically active plasmin by the addition of activator [21]. To
determine if PLG bound to recombinant proteins can acquire
proteolytic activity, 96-well plates were coated with the test
proteins, blocked, and then incubated with PLG. Unbound PLG
was washed away and the uPA-type PLG activator was added
together with a plasmin-specific chromogenic substrate. The
reaction was carried out overnight and the plasmin activity was
evaluated by measuring the cleavage of the plasmin-specific
chromogenic substrate (absorbance at 405 nm). As shown in
Fig. 4B, the PLG captured by the proteins could be converted into
plasmin, as demonstrated indirectly by specific proteolytic activity.
The negative control BSA did not bind PLG (see Fig. 4) and did
not show any proteolytic activity, as with the controls lacking PLG,
uPA or the chromogenic substrate.
Characterization of the binding of recombinant proteins
to PLG
The interactions between the recombinant proteins and PLG
were assessed on a quantitative basis as illustrated in Fig. 5A.
Dose-dependent and saturable binding was observed when
increasing concentrations (0 to 1,000 nM) of the recombinant
proteins MPL36, LipL40, LipL32, rLIC10494 and rLIC12238
were allowed to individually adhere to a fixed PLG amount (1 mg).
For the proteins Lp29, Lp49 and rLIC12730, the saturation level
was not reached, even at the highest concentration tested
(1,000 nM). Based on the ELISA data, the calculated dissociation
equilibrium constants (KD) for the recombinant proteins with PLG
are depicted in Fig. 5B; for the ones that reached equilibrium, the
highest and the lowest KD values were for LipL32
(25.8765.09 nM) and MPL36 (3.5263.95 nM), respectively.
Effects of salt and heparin on LipL32- and rLIC12238 -
plasminogen interactions
As the proteins LipL32 and rLIC12238 showed the highest
PLG binding and plasmin activity (Fig. 3B and Fig. 4B), they were
chosen for further studies. To verify whether binding of these
recombinant proteins to PLG is affected by added Cl
2 [47] or
negatively charged heparin [48], binding assays were performed in
the presence of different concentrations of NaCl or heparin. As
shown in Fig. 6A, the increase in Cl anions to physiological
conditions did not affect binding, and interference was only
detected at a higher salt concentration, 350 mM, for both
proteins. Similarly, the addition of heparin (up to 500 IU) did
not have any significant effect on the interaction of the proteins
with PLG (Fig. 6B).
Collagen type IV, but not plasma fibronectin, competes
with LipL32 for binding to PLG
LipL32 has been previously demonstrated to be a leptospiral
adhesin capable of binding collagen type IV and plasma
fibronectin [15,16]. To see if the extracellular matrix components
compete with LipL32 for the binding site of PLG or interfere
somehow in the interaction with PLG, the binding assay was
performed in the presence of increasing concentrations of collagen
type IV or plasma fibronectin. The results show that plasma
fibronectin had no effect on the binding of LipL32 to PLG (Fig. 7).
On the other hand, the addition of collagen type IV decreased
LipL32 binding to PLG in a dose-dependent fashion (Fig. 7),
suggesting that both molecules compete for the same binding site.
Discussion
The interaction of the human plasminogen system has been
suggested to be a feature that significantly contributes to the
virulence of many bacterial pathogens by facilitating the initial
anchoring to the endothelium [20]. Through capturing the host
PLG on its surface, followed by activation to enzymatically active
plasmin, the bacteria are turned into proteolytic organisms, a
characteristic that has been shown to contribute to the degradation
of ECM components, tissue penetration and invasion. In our
previous work, we showed that leptospires are capable of capturing
PLG on its outer surface and that the addition of exogenous
activator converted it into enzymatically active plasmin capable of
degrading ECM fibronectin [21]. In addition, multiple PLG-
binding proteins present in the L. interrogans serovar Copenhageni
whole cell lysates were detected, but remained unidentified [21].
Moreover, as expected, our data suggest the involvement of outer
membrane proteins in the binding. Indeed, Verma and colleagues
[27] have recently demonstrated that LenA, a surface leptospiral
Figure 1. SDS-PAGE analysis of purified recombinant proteins. Recombinant proteins were expressed in E. coli BL21 (DE3) or SI and purified
from the bacterial cell lysate using Ni
2+-charged chelating Sepharose columns. M: molecular mass protein marker.
doi:10.1371/journal.pone.0011259.g001
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availability of several putative surface-exposed recombinant
proteins of L. interrogans in our laboratory prompted us to
investigate the ability of these proteins to interact with PLG in
vitro, in order to reveal and extend the array of plasminogen
receptors in Leptospira.
The fourteen proteins selected for the screening of PLG binding
were cloned and expressed in E. coli as full-length recombinant
proteins. The purified proteins exhibited major bands in SDS-
PAGE making them suitable for PLG binding assays. The
structural integrity of the unpublished purified proteins was
attested by CD spectroscopy revealing a mixture of a-helix and
b–strand structures. The other recombinant proteins had their CD
spectra confirmed and were similar to the ones previously reported
[11,12,19,30,31,33]. The cellular localization of the proteins Lp29,
Lp49, LipL40, MPL36, rLIC10494, rLIC12730, rLIC12922 and
rLIC12238, was shown to be the cell surface, similar to findings for
the previously published LipL32 [28], Lsa63 [19], rLIC10509
[33], Lsa27 [11], MPL21 and MPL17 [31].
Several invasive gram-positive and gram-negative bacteria have
been shown to interact with the host PLG system [20,49,50,51,52],
a phenomenon that has also been observed with viruses [53,54,55]
and parasites [56], either by expression of PLG receptors or
stimulation of host activators. In the case of spirochetes, the
plasminogen activation system was studied with several species of
Borrelia with Treponema denticola and suggested to have an important
role during infection [22,23,24,25,26].
The human plasminogen heavy chain contains five triple-
disulfide-linked peptide regions of ,80 amino acids, called kringles
[57]. The process of binding to bacterial receptors on the cell
surface has been shown for several pathogens to be mediated by
the PLG kringle domains through the lysine-binding sites present
[20]. Similarly, Borrelia [24] and Leptospira [21] also bind PLG via
kringle domains. We have identified eight leptospiral plasminogen-
binding proteins: LipL32 [28,32], rLIC10494, rLIC12730 [12],
Lp29, Lp49 [30] and LipL40 and MPL36 [29] and one novel
protein rLIC12238. The specificity of the binding of these
recombinant proteins was attested by Western blotting. Interest-
ingly, two proteins showed disparate binding intensity by Western
blotting and ELISA. This could be explained by the fact that
ELISA is a quantitative method but Western blotting is not. In
addition, due to the denaturing condition of this latter method, it is
possible that the exposure of some epitopes led to better binding
for rLIC12730, while the inverse situation was seen with
rLIC12238 which apparently needs a more native condition for
PLG binding.
Plasminogen-binding proteins of B. burgdorferi, including the
outer-surface lipoprotein OspA, have been identified [41].
Recently, Brissette and coworkers [44] identified three proteins
of B. burgdorferi, ErpP, ErpA and ErpC, as being PLG-binding
proteins. Interestingly, an evaluation of the primary sequence of
spirochete PLG-binding proteins show that the proteins do not
share similarity, with the exception of the Erp family protein of B.
burgdorferi [44], BbCRASP-1 of B. hermsii [43] and HcpA of B.
recurrentis [40].
Our data with the PLG-binding proteins point out to a primary
role for lysine residues in plasminogen binding, as the lysine analog
6-aminocaproic acid (ACA) significantly inhibited binding
[21,27,58]. However, no correlation between the number of lysine
residues and PLG binding was detected. Indeed, the highest
percentage of lysine residues was identified in Lsa63 [19], a protein
that did not bind PLG. Moreover, lysine residue position does not
seem to correlate with binding because they were distributed
among all the protein sequences studied. This suggests that protein
conformation and steric hindrance should be important factors in
the binding of the protein/receptor to PLG. Plasminogen-binding
proteins were able to generate active plasmin in the presence of
urokinase-type PLG activator, as measured by the cleavage of
plasmin-specific chromogenic substrate.
The recombinant proteins bind to PLG in a concentration-
dependent and saturable fashion, indicating the specificity of the
binding, for the proteins LipL32, LipL40, MPL36, rLIC12238
and rLIC10494. The calculated dissociation equilibrium constants
(KD) for the recombinant proteins with PLG varied from
25.8765.09 nM for LipL32 to 3.5263.95 nM for MPL36. The
plasminogen interaction/activation has been shown to be
suppressed by the presence of Cl anions [47], while there is
Figure 2. Cellular localization of proteins in L. interrogans by L-
IFA. Protein recognition by L-IFA. Proteins in live L. interrogans serovar
Copenhageni isolates were recognized by FITC-conjugated antibodies
against Lp29, Lp49, LipL40, MPL36, LIC10494, LIC12730, LIC12922,
LIC12238 and LipL32 (surface-exposed lipoprotein, positive control), but
not against GroEL (a protoplasmic cylinder marker) and PBS (negative
control) under confocal microscopy. The leptospires were identified
using the DNA counterstain propidium iodide. Panels are composite
images of propidium iodide- and FITC-stained slides. Magnification,
6006.
doi:10.1371/journal.pone.0011259.g002
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PLoS ONE | www.plosone.org 5 June 2010 | Volume 5 | Issue 6 | e11259Figure 3. Binding of leptospiral recombinant proteins to human plasminogen. A. Theproteins were electrophoresed in 12% SDS-PAGE gels
and transferred to nitrocellulose membranes, followed by overnight incubation with 3 mg/mL PLG; after washing, the membrane was incubated with
mouse anti-human PLG (1:750), followed by incubation with anti-mouse IgG (1:5,000). Protein reactivity was revealed by ECL reagent/exposure to X-ray
films. B. The recombinant proteins LipL32, Lsa63, rLIC10509, Lp29, Lp49, Lsa27, MPL21, MPL17, LipL40, MPL36, rLIC10494, rLIC12730, rLIC12922 and
rLIC12238 were coated onto 96-well ELISA plates (10 mg/ml) and allowed to interact with purified human PLG (10 mg/ml). BSA was used as a negative
control for nonspecific binding. Binding was detected and quantified by specific antibodies. Bars represent the mean absorbance values at 492 nm 6
the standard deviation of four replicates for each protein and are representative of three independent experiments. * P,0.001; ** P,0.0001.
doi:10.1371/journal.pone.0011259.g003
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PLoS ONE | www.plosone.org 6 June 2010 | Volume 5 | Issue 6 | e11259evidence that heparin dextran derivatives could contribute to the
regulation of plasmin activity, not only by impeding plasmin
generation, as a result of their binding to plasminogen but also by
directly affecting the catalytic activity of the enzyme [48]. The
addition of Cl
2 did not inhibit LipL32 or rLIC12238-PLG
interactions, showing in fact, a positive effect with increasing
sodium chloride concentration. The presence of heparin had no
influence on the binding of either protein to PLG. Similar results
Figure 4. Role of lysine residues in recombinant protein-PLG interaction and activation to enzymatically active plasmin. A: Binding
of the immobilized proteins LipL32, Lp29, Lp49, LipL40, MPL36, rLIC10494, rLIC12730 and rLIC12238 (10 mg/ml) to PLG (10 mg/ml) was carried out in
the presence (PLG+ACA) or absence (PLG) of the lysine analogue 6-aminocaproic acid. BSA was used as a negative control for nonspecific binding.
The bound PLG was detected and quantified by specific antibodies. Bars represent the mean absorbance at 492 nm 6 the standard deviation of four
replicates for each sample and are representative of two independent experiments. Statistically significant differences are shown by * (P,0.001) and
** (P,0.0001). B: Cleavage of specific plasmin substrate by PLG bound to recombinant proteins was assayed by modified ELISA as immobilized
proteins received the following treatment: PLG+uPA+specific plasmin substrate (PLG+uPA+S), or controls lacking one of the three components
(PLG+uPA; PLG+S; uPA+S). BSA was employed as a negative control. Bars represent the mean absorbance values at 405 nm, as a measure of relative
substrate cleavage, 6 the standard deviation of four replicates for each experimental group and are representative of two independent experiments.
Statistically significant differences are shown by * (P,0.00001), ** (P,0.005) and *** (P,0.05).
doi:10.1371/journal.pone.0011259.g004
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both compoundsontheinteractionsofErpP recombinantproteinof
B. burgdorferi and plasminogen. Furthermore, Verma et al. [27]
showed that heparin had no effect on LenA-PLG interactions but
that the addition of salt led to an increase in binding.
The identified PLG-binding proteins Lp29, Lp49, LipL40 and
MPL36 have been previously reported to be reactive with sera from
leptospirosis patients [29,30] while rLIC12238 and rLIC10494
react with sera from hamsters infected with Leptospira (Nascimento,
AL et al., unpublished results). These data suggest that the proteins
are expressed and exposed during the course of infection. We
confirmed here the localization of these four proteins and presented
their PLG-binding properties. Taken together, our results implicate
that these proteins play a possible role in virulence.
The protein LipL32 is a major outer membrane antigen
expressed during mammalian infection [16,28]. It has been shown
that LipL32 is recognized by patients’ sera [15,59] and has the
ability to bind to ECM macromolecules [15], activities that suggest
a role in the pathogenesis of leptospires. Intriguingly, it has also
been demonstrated that LipL32 is not essential for either acute or
chronic infection with L. interrogans [60]. Here, we provide another
activity for LipL32, as a PLG-binding protein, giving further
support to its importance during infection. Additionally, our
results suggest that collagen type IV and PLG interact with the
same site of LipL32, a situation that does not occur with plasma
fibronectin. The dual activity of LipL32 in binding PLG and ECM
macromolecules together with our previous findings of fibronectin
degradation by plasmin-coated leptospires [21], may have
implications on the mechanisms of the invasion process.
In conclusion, we have identified and characterized eight
proteins as being PLG-binding proteins of Leptospira. There is
evidence that at least five of them (LipL32, Lp29, Lp49, LipL40
Figure 5. Characterization of recombinant proteins binding to PLG. A. PLG (10 mg/ml) was immobilized in 96-well ELISA plates, and each
recombinant protein at 0 to 1,000 nM was added for interaction. The binding was detected using antiserum raised in mice against each protein at
appropriate dilutions (1:4,000 for LipL32; 1:5,000 for rLIC12238, LipL40 and MPL36; 1:1,000 for Lp29 and Lp49; 1:500 for rLIC12730), followed by
horseradish peroxidase-conjugated anti-mouse IgG. Data represent the mean absorbance values 6 the standard deviation of six replicates for each
experimental group. The results are representative of two independent experiments. B. The dissociation constant (KD) was calculated based on ELISA
data for the recombinant proteins that reached equilibrium up to a concentration of 1,000 nM.
doi:10.1371/journal.pone.0011259.g005
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PLG-binding/activation through the proteins/receptors on the
surface of Leptospira could help the bacteria to specifically
overcome tissue barriers, facilitate invasion and colonize mam-
malian tissues. We believe that these studies provide new insights
into leptospiral pathogenesis and infection.
Materials and Methods
Bioinformatics characterization of the proteins
Predicted coding sequences (CDSs ) were analyzed as their
cellular localization predictions by PSORT program, http://psort.
nibb.ac.jp [61,62]. The web servers SMART, http://smart.
embl-heidelbergde/ [63,64], PFAM, http://www.sanger.ac.uk/
Software/Pfam/ [65], and LipoP, http://www.cbs.dtu.dk/services/
LipoP/ [66] were used to search for predicted functional and
structural domains within the amino acid sequences of the CDSs.
Cloning, expression and purification of recombinant
proteins
Amplification of the CDSs was performed by PCR from L.
interrogans serovar Copenhageni genomic DNA using complemen-
tary primer pairs. The gene sequences were amplified without the
signal peptide tag, predicted by SignalP (http://www.cbs.dtu.dk/
services/SignalP/ ). The final constructs were verified by DNA
sequencing on an ABI Prism 3730_L sequencer (Seq- Wright,
Figure 6. Effects of ionic strength and heparin in PLG binding by LipL32 and rLIC12238. Binding of LipL32 and rLIC12238 (10 mg/ml) to
immobilized PLG (10 mg/ml) was performed with the addition of increasing concentrations of NaCl (0 to 350 mM) (A) or heparin (0 to 500 IU) (B). The
detection of bound-PLG was assayed by specific antibodies. Bars represent the mean absorbance values 6 the standard deviation of four replicates
for each experimental group and are representative of two independent experiments. The data show statistically significant differences in A, shown
by * (P,0.05), but not in B.
doi:10.1371/journal.pone.0011259.g006
Figure 7. Effect of extracellular matrix macromolecules on PLG binding by LipL32. Binding of LipL32 (10 mg/ml) to immobilized PLG
(10 mg/ml) was performed with the addition of increasing concentrations of plasma fibronectin or collagen type IV (0 to 600 mM). The detection of
bound-PLG was assayed by specific antibodies. Bars represent the mean absorbance values 6 the standard deviation of four replicates for each
condition and are representative of two independent experiments. Results of statistically significant interference with binding in comparison with the
positive control (no addition of purified ECM macromolecules) are shown: P,0.0003 (*).
doi:10.1371/journal.pone.0011259.g007
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GACTCACTATAGGG) and pAE (R:CAGCAGCCAACT-
CAGTTCCT) primers. Cloning, expression and purification of
the recombinant proteins Lsa63, LIC10509, Lp29, Lp49 and
Lsa27 have been previously described [11,19,30,33]. The
sequences coding for MPL21, MPL17, MPL36, LipL40, LipL32,
LIC10494, LIC12730 and LIC12922 were cloned into the E. coli
Gateway cloning (pENTR) and expression (pDEST17) system
(Invitrogen), according to the protocol described elsewhere [29].
The expression and purification of MPL21 and MPL17 were
performed as reported elsewhere [31], and rLIC10494 and
rLIC12730, as previously described [12]. The recombinant
proteins MPL36 and LipL40 were purified from E. coli BL21
(DE3) and E. coli BL21-SI, respectively. Bacteria were grown in
Luria-Bertani (LB) broth with or without NaCl, at 37u or 30uC,
and at log-phase they were induced by 1 mM isopropyl-b-D-
thiogalactopyranoside (IPTG) or 3 mM NaCl for 3 h at 37uCo r
30uC, respectively. The bacteria cell lysates were cleared by
centrifugation at 3,0006g for 15 min, and the supernatants were
loaded onto Ni
2+-charged Sepharose beads. The beads were
washed with increasing concentrations of imidazole (20 to 60 mM)
and the proteins eluted with 0.5 M imidazole. The proteins
LipL32 and rLIC12922 were expressed in E. coli BL21-SI for 3 h
at 30uC with the addition of 150 mM NaCl to the log-phase
culture grown in LB broth without NaCl. The proteins were
expressed in the soluble form, as the above protocol described for
the proteins MPL36 and LipL40. The LIC12238 CDS was cloned
into the pGEM-T-Easy vector (Promega), and transferred into the
pAE expression vector [67]. The construct was transformed into
E. coli BL21-SI, and the log-phase culture, grown at 30uC, was
induced by incubation in the presence of 300 mM NaCl for 3 h.
The protein rLIC12238 was expressed in the soluble form and
purified as described above.
Circular dichroism spectroscopy
Purified recombinant proteins were dialyzed against sodium
phosphate buffer (pH 7.4). Circular dichroism (CD) spectroscopy
measurements were performed at 20uC using a Jasco J-810
spectropolarimeter (Japan Spectroscopic, Tokyo) equipped with a
Peltier unit for temperature control. Far-UV CD spectra were
measured using a 1 mm-path length cell at 0.5 nm intervals. The
spectra were presented as an average of five scans recorded from
180 to 260 nm. The molar ellipticity (W) is expressed in
deg.cm
2.dmol
21.
Antisera production against recombinant proteins
The recombinant proteins were adsorbed onto 10% (vol/vol) of
Alhydrogel (2% Al (OH)3, Brenntag Biosector, Denmark), used as
adjuvant. Each recombinant protein (10 mg) was subcutaneously
injected in female BALB/c mice (4–6 weeks old). Two subsequent
booster injections were given at two-week intervals with the same
protein preparations. Negative-control mice were injected with
PBS/Alhydrogel. Two weeks after each immunization, the mice
were bled from the retro-orbital plexus, and the pooled sera were
analyzed by enzyme-linked immunosorbent assay for the deter-
mination of antibody titers. All animal studies were approved by
the Ethics Committee of Instituto Butantan, under protocol 506/
08, Sa ˜o Paulo, SP, Brazil.
Liquid-phase immunofluorescence assay (L-IFA)
The localization of the recombinant proteins by L-IFA was
performed as previously described [31]. In brief, 2.5-ml suspen-
sions of live leptospires (L. interrogans serovar Copenhageni strain M
20, routinely cultured as described elsewhere [21] were harvested
at 10,000 rpm for 15 min, washed twice with PBS (with 50 mM
NaCl), resuspended in 200 ml of PBS with 6 mg/ml propidium
iodide to stain the nuclei, and incubated for 45 min at 37uC. After
incubation, the leptospires were gently washed with PBS and
incubated for 30 min at 4uC with polyclonal mouse antiserum
against each recombinant protein or GroEL at a 1:50 dilution.
The leptospires were washed and incubated with goat anti-mouse
IgG antibodies conjugated to fluorescein isothiocyanate (FITC,
Sigma) at a dilution 1:50 for 30 min at 4uC. After incubation with
secondary antibody, the leptospires were washed and resuspended
in PBS-antifading solution (ProLong Gold, Molecular Probes).
The immunofluorescently labeled leptospires were examined with
the use of a confocal LSM 510 META immunofluorescence
microscope (Zeiss, Germany).
Plasminogen binding
The binding of the recombinant proteins to PLG was evaluated
by a modified ELISA as follows: 96-well plates (Costar High
Binding, Corning) were coated overnight in PBS at 4uC with
100 mlo f1 0mg/ml of the recombinant proteins or bovine serum
albumin (BSA) as negative control. Plates were washed once with
PBS supplemented with 0.05% (vol/vol) Tween 20 (PBS-T) and
blocked for 2 h at 37uC with PBS with 10% (wt/vol) non-fat dry
milk. The blocking solution was discarded and 100 mlo f1 0mg/ml
human plasminogen in PBS was incubated for 2 h at 37uC. Wells
were washed four times with PBS-T and incubated for 1 h at 37uC
with mouse anti-human plasminogen (Sigma-Aldrich) (1:4,000 in
PBS). Plates were washed again and incubated with horseradish
peroxidase-conjugated anti-mouse immunoglobulin G (IgG),
diluted 1:5,000 in PBS. After three washings, 100 ml/well of
1 mg/ml o-phenylenediamine (OPD) plus 1 ml/ml H2O2 in citrate
phosphate buffer (pH 5.0) were added. The reactions were carried
out for 5 min and stopped by the addition of 50 ml/well of H2SO4
(2 N). Readings were taken at 492 nm.
Effects of salt and heparin on recombinant proteins-
plasminogen interactions
To assess the role of ionic interactions or of heparin-binding
domains in LipL32 or rLIC12238 binding to plasminogen,
increasing concentrations of NaCl (0–350 mM) or heparin (0–
500 IU) (Roche) were added to the PBS-based buffer with
plasminogen to the recombinant protein-coated wells. In both
experiments, the detection of bound-plasminogen was performed
as described above.
SDS-PAGE and affinity blotting
The purified recombinant proteins were electrophoresed in
12% SDS-PAGE gels and transferred to nitrocellulose membranes
(Hybond-ECL, GE Healthcare) in semi-dry equipment. The
membranes were blocked with 5% BSA for 2 h at 37uC, washed
three times (10 min for each wash) with PBS-0.5% Tween-20
solution and incubated overnight with 3 mg/mL PLG 4uC,
followed by 2h incubation at room temperature. The membranes
were then washed three times and incubated with mouse anti-
human PLG (1:750) for 3 h at room temperature, followed by
three more washings and 1 h incubation at room temperature with
anti-mouse IgG (1:5,000). The membranes were washed and the
protein’s reactivity was revealed using the ECL reagent (GE
Healthcare) with subsequent exposure to X-ray films.
Characterization of the binding
To determine the role of lysines in plasminogen-recombinant
protein interactions, the lysine analog 6-aminocaproic acid (ACA)
PLG-Receptors of Leptospira
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concentration of 2 mM to the recombinant protein-coated wells.
To assess the role of ionic interactions or of heparin-binding
domains in LipL32 or rLIC12238 binding to plasminogen,
increasing concentrations of NaCl (0–350 mM) or heparin (0–
500 IU) (Roche) were added to the PBS-based buffer with
plasminogen which was then added to the recombinant protein-
coated wells. In both experiments, the detection of bound-
plasminogen was performed as described above.
Plasmin enzymatic activity assay
First, 96-well ELISA plates were coated overnight with 10 mg/
ml recombinant proteins or BSA in PBS at 4uC. Plates were then
washed once with PBS-T and blocked with PBS with 10% (wt/vol)
non-fat dry milk for 2 h at 37uC. The blocking solution was
discarded and 100 ml/well of 10 mg/ml human plasminogen was
added, followed by incubation for 2 h at 37uC. Wells were washed
three times with PBS-T, and then 4 ng/well of human uPA
(Sigma-Aldrich) were added. Subsequently, 100 ml/well of the
plasmin-specific substrate D-valyl-leucyl-lysine-p-nitroanilide dihy-
drochloride (Sigma-Aldrich) was added at a final concentration of
0.4 mM in PBS. Plates were incubated overnight at 37uC and
substrate was measured by taking readings at 405 nm.
Dose-response curves
First, 96-well ELISA plates were coated overnight in PBS at 4uC
with 100 mlo f1 0mg/ml plasminogen. Plates were then blocked
and increasing concentrations of the purified recombinant proteins
(0–1 mM) were added (100 ml/well in PBS). The assessment of
bound proteins was performed by incubation for 1 h at 37uC with
the antiserum raised against each protein at appropriate dilutions
(1:4,000 for LipL32; 1:5,000 for rLIC12238, LipL40 and MPL36;
1:1,000 for Lp29 and Lp49; 1:500 for rLIC12730), followed by
horseradish peroxidase-conjugated anti-mouse IgG (Sigma)
(1:10,000 in PBS). The binding was evaluated by the peroxidase
substrate OPD and readings were taken at 492 nm. The ELISA
data were used to calculate the dissociation constant (KD)
according to the method described by Pathirana et al. [68] and
Lin et al. [69], based on the equation: A=Amax [protein]/
(KD+[protein]), where A is the absorbance at a given protein
concentration, Amax is the maximum absorbance for the ELISA
plate reader (equilibrium), [protein] is the protein concentration
and KD is the dissociation equilibrium constant for a given
absorbance at a given protein concentration (ELISA data point).
Interference of collagen type IV and plasma fibronectin
with PLG binding by LipL32
First, 96-well plates were coated overnight at 4uC with 100 mlo f
10 mg/ml recombinant LipL32 in PBS, washed once and blocked
with 10% (w/v) non-fat dry milk for 2 h at 37uC. The plates were
then incubated for 2 h at 37uC with 200 nM PLG together with
increasing concentrations of collagen type IV (Sigma-Aldrich) or
plasma fibronectin (Sigma-Aldrich) (both from 0 to 600 nM). After
four washings, PLG binding was quantified by specific antibodies
as described above.
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